老虎证券

BUZZ-Organon rises after agreeing to sell postpartum bleeding device to Laborie for up to $465 mln

Reuters
2025/11/07
BUZZ-Organon rises after agreeing to sell postpartum bleeding device to Laborie for up to $465 mln

** Shares of healthcare firm Organon OGN.N rise 2% to $6.85 premarket

** Co says it will sell its JADA System, a device used to treat postpartum bleeding, to Laborie Medical Technologies for up to $465 million

** Deal includes $440 mln upfront, $25 mln tied to 2026 sales targets – OGN

** OGN says ~100 of it's employees will move to Laborie as part of the agreement

** The JADA System, which OGN acquired in 2021, is used to manage postpartum hemorrhage, a serious complication after childbirth - OGN

** The transaction is expected to close in the first quarter of 2026, pending regulatory approvals, co says

** Up to last close, stock down ~55% YTD

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10